High Apolipoprotein B Levels are Associated with an Increased Risk of Recurrent Acute Ischemic Stroke: A Nested Case–Control Study
Open Access
- 28 October 2025
- journal article
- research article
- Published by Springer Nature in Translational Stroke Research
- Vol. 16 (6) , 2035-2046
Abstract
Mendelian randomization studies have identified that apolipoprotein B (ApoB) is the primary genetic determinant of ischemic stroke, rather than other lipidKeywords
Funding Information
- 2020 Medical Research Project of the Jiangsu Provincial Health Commission (No. ZDA2020018)
- the fifth 333 High level Talents funding project of Jiangsu Province (No. BRA2019247)
This publication has 33 references indexed in Scilit:
- Apolipoprotein B vs Low-Density Lipoprotein Cholesterol and Non–High-Density Lipoprotein Cholesterol as the Primary Measure of Apolipoprotein B Lipoprotein-Related RiskJAMA Cardiology, 2022
- Cumulative risk of stroke recurrence over the last 10 years: a systematic review and meta-analysisNeurological Sciences, 2020
- Circulating Lipoprotein Lipids, Apolipoproteins and Ischemic StrokeAnnals of Neurology, 2020
- Inflammation, Immunity, and Infection in AtherothrombosisJACC, 2018
- Hospital-Based Study of the Frequency and Risk Factors of Stroke Recurrence in Two Years in ChinaJournal of Stroke and Cerebrovascular Diseases, 2017
- Association of Genetic Variants Related to CETP Inhibitors and Statins With Lipoprotein Levels and Cardiovascular RiskJAMA, 2017
- Serum albumin level is associated with the recurrence of acute ischemic strokeThe American Journal of Emergency Medicine, 2016
- A Century of Cholesterol and Coronaries: From Plaques to Genes to StatinsCell, 2015
- Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trialsThe Lancet, 2010
- Atherogenic Dyslipidemia: Cardiovascular Risk and Dietary InterventionLipids, 2010